The S&P 500 (SP500) closed in the red on Friday, with Nasdaq (COMP:IND) falling 2.8% during the week. Wall Street had a slew of upgrades and downgrades from analysts. Here are some of the major calls ...

Shoppers are changing how they approach gift-giving this holiday season, focusing less on flash and more on value. A new ...

Losing weight doesn’t have to mean drastic diets or complicated meal plans. Research shows that small, sustainable changes to ...

Pfizer is buying out Metsera for up to $10 billion after an acquisition battle with another pharma giant. Metsera's leading ...

The hemp industry is facing a time bomb as a new law will ban over 95% of hemp extract products, with a few exceptions, ...

Revolutionary breakthroughs in neuroscience and metabolism research are transforming the landscape of weight loss strategies.

The world’s most valuable healthcare stock, Eli Lilly and Company (NYSE: LLY), just dropped huge news. Like Pfizer (NYSE: PFE), Lilly announced a drug pricing deal with the Trump Administration. Below ...

Gain insight on bidding wars in the pharmaceuticals sector, Novo Nordisk and more in the latest Market Talks covering the health care sector.

President Donald Trump appeared to be nodding off as officials spoke at a recent White House event focused on health and ...

Novo Nordisk’s ($NVO) shares fell modestly on Friday after its recent boardroom drama culminated in its top owner securing 90 ...

Danish drugmaker H. Lundbeck has made an unsolicited bid worth up to $2.25 billion for Avadel Pharmaceuticals, potentially ...

Lars Rebien Sorensen is back as chairman of Novo Nordisk A/S following a shareholder meeting that exposed the depth of rivalry between the Danish drugmaker and US arch nemesis Pfizer Inc.